CMEOF (Creo Medical Group) Change In Inventory: $0.26 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CMEOF Creo Medical Group PLC CMEOF
52 GF Score
Price $0.20
GF Value $0.26
! 6 Warning Signs
View Full Analysis

What is Creo Medical Group Change In Inventory?

Creo Medical Group CMEOF 52 Change In Inventory is $0.26 Mil as of Dec. 2025. GuruFocus rates CMEOF with a GF Score™ of 52/100 and a GF Value™ of $0.26. The stock has 6 warning signs investors should review.

Creo Medical Group's change in inventory for the quarter that ended in Dec. 2025 was $0.54 Mil. It means Creo Medical Group's inventory declined by $0.54 Mil from Jun. 2025 to Dec. 2025 .

Creo Medical Group's change in inventory for the fiscal year that ended in Dec. 2025 was $0.27 Mil. It means Creo Medical Group's inventory declined by $0.27 Mil from Dec. 2024 to Dec. 2025 .

Creo Medical Group's Total Inventories for the quarter that ended in Dec. 2025 was $3.35 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Creo Medical Group's Days Inventory for the quarter that ended in Dec. 2025 was 218.37.

Inventory Turnover measures how fast the company turns over its inventory within a year. Creo Medical Group's Inventory Turnover for the quarter that ended in Dec. 2025 was 0.84.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Creo Medical Group's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.76.

Creo Medical Group  (OTCPK:CMEOF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Creo Medical Group's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=3.8445/3.213*365 / 2
=218.37

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Creo Medical Group's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=3.213 / 3.8445
=0.84

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Creo Medical Group's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=3.8445 / 5.087
=0.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Creo Medical Group Change In Inventory Related Terms

Creo Medical Group Change In Inventory Historical Data

* Premium members only.

The historical data trend for Creo Medical Group's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Creo Medical Group Change In Inventory Chart

Creo Medical Group Annual Data
Trend Feb15 Feb16 Jun17 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.95 -0.37 -0.51 0.89 0.27

Creo Medical Group Semi-Annual Data
Feb15 Feb16 Dec16 Jun17 Dec17 Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.77 -0.38 1.26 -0.27 0.54
CMEOF
52GF Score
Creo Medical Group PLC CMEOF
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Creo Medical Group Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of $0.26 Mil mean?
Creo Medical Group (CMEOF) has a Change In Inventory of $0.26 Mil as of Dec. 2025. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Creo Medical Group and its competitors.
Is Creo Medical Group's Change In Inventory too high?
Creo Medical Group's current Change In Inventory is $0.26 Mil. Overall, Creo Medical Group has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Creo Medical Group's Change In Inventory compare to ABT and SYK?
Creo Medical Group's Change In Inventory of $0.26 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Medical Devices & Instruments company?
A good Change In Inventory depends on the Medical Devices & Instruments industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Creo Medical Group and its competitors. Creo Medical Group's current Change In Inventory is $0.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creo Medical Group stock overvalued right now?
Creo Medical Group (CMEOF) has a current Change In Inventory of $0.26 Mil. The stock's GF Value™ is $0.26, compared to a current price of $0.20 — trading 23.1% below its estimated fair value. The current Change In Inventory is $0.26 Mil. Creo Medical Group's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Creo Medical Group (CMEOF), the current Change In Inventory is $0.26 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Creo Medical Group (CMEOF) Overvalued in 2026?

Based on GuruFocus' analysis, Creo Medical Group stock appears to be undervalued. The current stock price of $0.20 is trading 23.1% below its estimated GF Value™ of $0.26.

Key valuation signals for CMEOF:

  • Change In Inventory: $0.26 Mil
  • GF Value™: $0.26 vs. price of $0.20 (23.1% below fair value)
  • GF Score™: 52/100 with 6 warning signs

No single metric tells the full story. See the CMEOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Creo Medical Group Business Description

Other Exchanges CREO:UK
Address Beaufort Park Way, Unit 2, Creo House, Beaufort Park, Chepstow, GBR, NP16 5UH
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy. Geographically, the company generates a majority of its revenue from United Kingdom and the rest from Europe and the rest of the world.
52GF Score

Get the complete analysis for CMEOF

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.20
Price
$0.26
GF Value